Citations with the tag: TRANSDERMAL medication

Results 1 - 50

• Critical role of PSAs in transdermal drug delivery.
  Barnhart, Scott; Carrig, Tom // Adhesives & Sealants Industry; Apr98, Vol. 5 Issue 3, p26 

  States that transdermal drug delivery patches which deliver medication through the skin are being embraced by the pharmaceutical industry and the public. Details on the 1970's introduction of the system; Indepth look at Transdermal drug-delivery systems (TDDS); Indication that patient...

• Ultrasound: Route of choice for meds in the future?
  Begany, Timothy // RN; Mar96, Vol. 59 Issue 3, p14 

  Provides information on a technique on sonophoresis, a method of transdermal drug delivery, which scientists hope will replace injections. What is involved in sonophoresis; What progress has been made.

• Transdermal drug delivery: Vehicle design and formulation.
  Pefile, Sibongile; Smith, Eric W. // South African Journal of Science; Apr97, Vol. 93 Issue 4, p147 

  Describes the properties of the delivery system most desirable for the formulation of transdermal drug delivery preparations. Rate of diffusion; Bioavailability of the drug under different physiological conditions; Factors to be taken into account for the formulation of semi-solids.

• Sound medicine.
  Dixon, Bernard // BMJ: British Medical Journal (International Edition); 10/14/95, Vol. 311 Issue 7011, p1030 

  Provides information on the medical benefits of transdermal drug delivery. Efforts by researchers to use chemicals to make the skin more permeable to various drugs; Sonophoresis.

• Transdermal patch helps control cancer pain.
  Dixon, Bernard // Urology Times; Oct96, Vol. 24 Issue 10, p40 

  Focuses on cancer patients' satisfaction with transdermal fentanyl by Janssen.

• Skin Patches: New Warning Issued.
  Dixon, Bernard // Clarendon Enterprise (TX); 4/9/2009, Vol. 20 Issue 15, p12 

  The article presents a medical warning on skin patches in the U.S.

• Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care.
  McNamara, Paul // Palliative Medicine; Sep2002, Vol. 16 Issue 5, p425 

  The study objective was to determine whether switching patients from morphine to transdermal fentanyl resulted in a reduction of morphine-associated side effects, and an improvement in cognitive function and patients' well being while maintaining adequate pain and symptom control. Nineteen...

• A new method to obtain and present complete information on the compatibility: study of its validity for eight binary mixtures of morphine with drugs frequently used in palliative care.
  Vermeire, An; Remon, Jean Paul; Schrijvers, Dirk; Demeulenaere, Peter // Palliative Medicine; Sep2002, Vol. 16 Issue 5, p417 

  Parenteral administration of mixtures of morphine with other drugs has become common practice in palliative care. Such mixtures are sometimes found to be incompatible but compatibility data are scarce. An attempt was made to develop a quick and simple investigation strategy to obtain complete...

• Testoderm patch gets new code.
  Vermeire, An; Remon, Jean Paul; Schrijvers, Dirk; Demeulenaere, Peter // Drug Topics; 8/8/94, Vol. 138 Issue 15, p8 

  Reports on the National Drug Code numbers assigned to Alza Pharmaceutical's Testoderm Testosterone Transdermal System.

• Nicotine patches plus counseling effective, but relapse is common.
  Vermeire, An; Remon, Jean Paul; Schrijvers, Dirk; Demeulenaere, Peter // Geriatrics; Aug93, Vol. 48 Issue 8, p68 

  Reports on a study indicating that among general hospital outpatients, the combination of transdermal nicotine patches and low-intensity support can lead to smoking cessation. Common occurrence of relapse after six weeks; Effects on patients treated for smoking-related diseases.

• MIMS UPDATE.
  Vermeire, An; Remon, Jean Paul; Schrijvers, Dirk; Demeulenaere, Peter // GP: General Practitioner; 6/3/2002, p72 

  Features the Transtec transdermal matrix patch from Napp and erection pumps from Owen Mumford. Use of the patch in treating malignant and non-malignant severe pain; Active ingredient of the patch; Restrictions applied on the pumps.

• Suppression of ovulation by transdermal oestradiol patches.
  Watson, N.R.; Studd, J.W.W.; Riddle, A.F.; Savvas, M. // BMJ: British Medical Journal (International Edition); 10/8/88, Vol. 297 Issue 6653, p900 

  Examines the effect of transdermal estradiol patches on ovulation. Description of percutaneous estrogen; Performance of ultrasonography; Occurrence of follicular rupture in patients.

• Nicotine replacement is safe in stable CAD.
  Watson, N.R.; Studd, J.W.W.; Riddle, A.F.; Savvas, M. // Patient Care; 6/15/1994, Vol. 28 Issue 11, p162 

  Highlights the results of the study `Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease: Nicotine replacement therapy for patients with coronary artery disease,' from the journal `Archives of Internal Medicine.' Efficacy of transdermal nicotine patches...

• Confessions of a Parenteral Wuss.
  Rios, Maribel // Pharmaceutical Technology North America; May2002, Vol. 26 Issue 5, p12 

  Focuses on the availability of transdermal drug delivery systems (TDDS) for a wide range of therapies. Constituents of a TDDS design; Details on the polymers used in commercial TDDS; Selection of proper polymer for a specific application.

• Transdermal anticholinergic shows fewer side effects.
  Alexander, Walter // Urology Times; Jan2002, Vol. 30 Issue 1, p14 

  Investigates the effects of transdermal oxybutynin drugs on overactive bladder. Decrease in urge incontinence episodes; Increase in void volume; Adverse effects of transdermal oxybutynin.

• Transdermal testosterone gel safe over long term.
  Tennant, Scott // Urology Times; Oct2002, Vol. 30 Issue 10, p7 

  Reports on the safety and efficacy profile of transdermal testosterone gel despite long term use according to the Endocrine Society. Patient characteristics; Drug dose of the gel for up to 42 months; Absence of adverse skin effects; Precaution for men with elevated prostate specific antigen;...

• First combination estrogen-progestin patch.
  Rose, Verna L. // American Family Physician; 11/15/98, Vol. 58 Issue 8, p1906 

  Introduces the CombiPatch, the first transdermal hormone replacement therapy approved by the United States Food and Drug Administration. Trials conducted on the drug; Contraindication of the combined use of estrogen and progestin.

• Iontophoresis: Applications in transdermal medication delivery.
  Costello, Charles T.; Jeske, Arthur H. // Physical Therapy; Jun1995, Vol. 75 Issue 6, p104 

  Presents a review of the literature relating to iontophoresis, a technique for introducing ionic medications through the skin. History of iontophoresis; Physico-chemical and biological factors affecting iontophoretic drug transfer; Factors affecting skin injury; Techniques for optimizing...

• PITCHING PATCHES: DRUG COMPANIES TARGET THE CONSUMER.
  Ettorre, Barbara // Management Review; May92, Vol. 81 Issue 5, p8 

  Discusses U.S. pharmaceutical companies' advertising of their anti-smoking transdermal patches to consumers. Proliferation of print and television advertisements for Nicoderm and Habitrol nicotine patches; Television advertisements' omission of the drug's function; U.S. regulations covering the...

• Structure-activity Relationship of Chemical Penetration Enhan-cers in Transdermal Drug Delivery.
  Kanikkannan, N.; Kandimalla, K.; Lamba, S.S.; Singh, M. // Current Medicinal Chemistry; Jun2000, Vol. 7 Issue 6, p593 

  Transdermal drug delivery (TDD) is the administration of therapeutic agents through intact skin for systemic effect. TDD offers several advantages over the conventional dosage forms such as tablets, capsules and injections. Currently there are about eight drugs marketed as transdermal patches....

• Breaking the skin barrier.
  Wickelgren, Ingrid // Popular Science; Dec96, Vol. 249 Issue 6, p86 

  Focuses on the issue of transdermal drug delivery. Research of chemical engineer Robert Langer on the use of pulses of sound to slip medicines through the skin; Brief history of transdermal drug delivery; Chemical tack taken by researchers at Theratech; Method called iontophoresis; Technique...

• Patch for testosterone deficiency in men.
  Wickelgren, Ingrid // Modern Medicine; Apr98, Vol. 66 Issue 4, p59 

  Introduces the transdermal testosterone, a patch indicated as a hormone replacement therapy for testosterone deficient men from Alza Corporation. Indication of the patch; Mechanism of action.

• Heat-associated increase in transdermal fentanyl absorption.
  Carter, Kathy A. // American Journal of Health-System Pharmacy; 1/15/2003, Vol. 60 Issue 2, p191 

  Discusses the study on effect of heat on transdermal absorption of fentanyl, a potent narcotic analgesic used for sedation and relief of acute pain. Dosage forms in which the drug is available; Factors on which the transdermal absorption of fentanyl is dependent; Different cases in which the...

• The Potential of Metabolic Interventions to Enhance Transdermal Drug Delivery.
  Elias, Peter M.; Tsai, Janice; Menon, Gopinathan K.; Holleran, Walter M.; Feingold, Kenneth R. // Journal of Investigative Dermatology; Dec2002 Supplement, Vol. 119, p79 

  The stratum corneum is a complex tissue that is metabolically active, and undergoes dynamic structural modifications due to the presence of several self-regulating enzymatic systems. A large number of defensive (protective) functions are embodied in this tissue, each with its own structural and...

• ALLERGIC DISORDERS.
  Elias, Peter M.; Tsai, Janice; Menon, Gopinathan K.; Holleran, Walter M.; Feingold, Kenneth R. // MPR - Residents' Edition; Spring/Summer2009, Vol. 18 Issue 1, p1 

  The article lists several drugs for allergic disorders including the Anthistamine, Leukotriene receptor antagonist, and Sympathomimetic.

• A Different Kind of Patch.
  Sellers, L.J. // Pharmaceutical Executive; Mar2002, Vol. 22 Issue 3, p34 

  Reports the launching of transdermal patch from Sequella. Forecast on the sales of the product; Utilization of the product for tuberculosis diagnosis.

• A welcome patch on the back.
  Sellers, L.J. // Men's Health (10544836); Apr98, Vol. 13 Issue 3, p26 

  Introduces a transdermal patch that may relieve back pain. Type of painkiller delivered by the patch; Result of product testing; Cost of each patch.

• Laser assists transdermal drug delivery.
  Lewotsky, Kristin // Laser Focus World; Mar97, Vol. 33 Issue 3, p20 

  Reports on the transdermal drug-delivery laser that allows painless administration without the use of needles for the local anesthetic administration of lidocaine, a research developed at University Of Arkansas Medical Sciences Center. Advantages of the device; Results on trials conducted on...

• Transdermal nicotine effects on attention.
  Levin, E. D.; Conners, C. Keith; Silva, Donna; Hinton, Sean C.; Meck, Warren H.; March, John; Rose, Jed E. // Psychopharmacology; 1998, Vol. 140 Issue 2, p135 

  Abstract Nicotine has been shown to improve attentiveness in smokers and attenuate attentional deficits in Alzheimer's disease patients, schizophrenics and adults with attention-deficit/hyperactivity disorder (ADHD). The current study was conducted to determine whether nicotine administered via...

• Hepatitis With Cholestasis Caused by Rivastigmine Transdermal Patch.
  Mumoli, Nicola; Carmignani, Giovanni; Luschi, Riccardo; Cei, Marco; Chiavistelli, Patrizio // American Journal of Gastroenterology; Nov2009, Vol. 104 Issue 11, p2859 

  A letter to the editor is presented which focuses on an 84-year-old woman with transdermal mixed cholestatic and hepatocellular injury induced by rivastigmine.

• Tapemark Expands Transdermal Capabilities.
  Mumoli, Nicola; Carmignani, Giovanni; Luschi, Riccardo; Cei, Marco; Chiavistelli, Patrizio // Contract Pharma; Mar2013, Vol. 15 Issue 2, p130 

  The article discusses the addition of several capabilities for transdermal patches from Tapemark including blending, formulation and coating steps in the manufacturing process of the patch.

• Research Brief: Influenza vaccination.
  Mumoli, Nicola; Carmignani, Giovanni; Luschi, Riccardo; Cei, Marco; Chiavistelli, Patrizio // GP: General Practitioner; 7/23/2010, p17 

  The article cites a research published in a 2010 issue of the periodical "Nature Medicine Online," which concludes that influenza vaccines could be delivered to skin instead of muscle.

• Flu Shot in a Patch.
  Park, Alice // Time; 8/2/2010, Vol. 176 Issue 5, p15 

  The article notes that a skin patch embedded with microneedles has been developed to deliver flu vaccines.

• Flu Shot in a Patch.
  Park, Alice // Time International (Atlantic Edition); 8/2/2010, Vol. 176 Issue 5, p8 

  The article notes that a skin patch embedded with microneedles has been developed to deliver flu vaccines.

• RC in talks to partner with transdermal delivery firm.
  Park, Alice // Medical Device Daily; 5/22/2013, Vol. 17 Issue 99, p4 

  The article reports that drug delivery firm Rainbow Coral started negotiations with a potential partner in the development of transdermal patches.

• Glyceryl Trinitate Has Fewer Side Effects than Ritodrine.
  Walling, Anne D. // American Family Physician; 02/15/2000, Vol. 61 Issue 4, p1177 

  Discusses the study `Maternal and Fetal Cardiovascular Effects of Transdermal Glyceryl Trinitrate and Intravenous Ritodrine,' by R.S. Black and colleagues published in the October 1999 issue of the `Obstetrics and Gynecology' journal.

• OXYTROL(TM) (OKS-ee-trol) (SKIN PATCH).
  Walling, Anne D. // Drug Topics; 4/7/2003, Vol. 147 Issue 7, p19 

  Offers information on a skin patch called Oxytrol, which is used to treat overactive bladder. Enabling of the user to have more control over the need to urinate; Conditions under which the medicine should not be used; Guidelines on how to use, store and dispose of the medicine; Drugs and foods...

• NEW DOSAGE STRENGTHS.
  Walling, Anne D. // Drug Topics; 8/18/2003, Vol. 147 Issue 16, p70 

  Reports on the approval of two strengths of Climara from Berlex Laboratories for once-weekly transdermal estrogen patches.

• Quitters or not, patients still like nicotine patches.
  Starr, Cynthia // Drug Topics; 11/22/93, Vol. 137 Issue 22, p24 

  Presents a study of what patients think of nicotine patches, the process they go through to procure these and what they learned from health professionals involved in their care. Users who are satisfied and who would use the product again if additional treatment were needed; Support from...

• Drug Dispensers.
  Perros, George // Paper, Film & Foil Converter; Oct2003, Vol. 77 Issue 10, p49 

  Discusses the opportunities offered by transdermal patches for companies that manufacture drug patches and their supply chain partners. Components of transdermal delivery system; Major market driver for the over-the-counter patch; Types of transdermal delivery system products; Emerging and...

• Cannon Fodder.
  Perros, George // Design Engineering; Mar2000, p6 

  Focuses on the conceptualization of the Transdermal Nutrient Delivery System for soldiers in the United States. Transmission of vitamins and nutrients into the bloodstream; Determination of metabolic requirements; Activation of microelectrical mechanical system to transmit the nutrients.

• Patch up the baby blues.
  Perros, George // Joe Weider's Muscle & Fitness; Aug97, Vol. 58 Issue 8, p34 

  Reports on the treatment of postpartum depression in women, with the use of transdermal estrogen administered through a skin patch. How the condition affects women; Reference to research on estrogen patches.

• Transdermal drug administration--a nuisance becomes an opportunity.
  Shaw, Jane E.; Urquhart, John // British Medical Journal (Clinical Research Edition); 10/3/1981, Vol. 283 Issue 6296, p875 

  Focuses on the issues surrounding the transdermal drug administration. Concern on the systemic side effects of transdermal permeation of drugs; Factors influencing the rate of systemic drug absorption; Accounts on the first transdermal therapeutic system introduced in the United States.

• Developing Custom Adhesive Systems for Transdermal Drug Delivery Products.
  Hopp, Melinda S. // Pharmaceutical Technology North America; Mar2002, Vol. 26 Issue 3, p30 

  Looks into the market acceptance on the development of adhesive systems for transdermal drug delivery systems in the U.S. Methods of drug administration; Delivery of materials like nicotine for smoking cessation; Challenges for specialty adhesives manufacturers.

• Nicotine patches in general practice.
  Campbell, I.A. // BMJ: British Medical Journal (International Edition); 5/15/93, Vol. 306 Issue 6888, p1284 

  Examines efficacy of nicotine patches on mitigating craving and withdrawal symptoms in Great Britain. Ability of smoker to tolerate effect of erythema, oedema and itching following treatment; Assessment on efficacy of transdermal nicotine on controlling craving and mood disturbances; Usability...

• Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice.
  Campbell, I.A. // BMJ: British Medical Journal (International Edition); 5/15/93, Vol. 306 Issue 6888, p1304 

  Assesses effectiveness of nicotine patch on helping people stop smoking. Value of support booklet about smoking cessation; Comparison on efficacy between patch and advice pamphlet; Importance of nursing support on effectiveness of treatment.

• Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.
  Russell, M.A.H.; Stapleton, J.A.; Feyerabend, C.; Wiseman, S.M.; Gustavsson, G.; Sawe, U.; Connor, P. // BMJ: British Medical Journal (International Edition); 5/15/93, Vol. 306 Issue 6888, p1308 

  Evaluates efficacy of transdermal nicotine patches as aid to stopping smoking. Effect of nicotine patch dosage increase on rate of initial cessation; Impact of patches on reducing craving and adverse mood changes; Assessment on systemic effects attributable to nicotine.

• New laser modality improves transdermal delivery of 5-FU.
  Bryant, Rebecca // Dermatology Times; Oct2002, Vol. 23 Issue 10, p43 

  Reports that laser pretreatment dramatically increases the transdermal delivery of the chemotherapeutic agent, 5-FU according to a study presented at the Society for Investigative Dermatology annual meeting. Effectiveness when used with superficial ablation; Mechanism of action.

• Derm drugs pose serious fetal risks.
  Guttman, Cheryl // Dermatology Times; Aug2002, Vol. 23 Issue 8, p16 

  Focuses on the need to ensure the safety of prescribing dermatologic drugs to pregnant women in New York. Assurance on the contraindications of the drugs; Need to impose pretherapy screening on pregnant women taking the drugs;Importance to have an open conversation with the client on the...

• Clinical Briefs.
  Guttman, Cheryl // Dermatology Times; Aug2002, Vol. 23 Issue 8, p18 

  Reports issues related to transdermal drugs as of August 2002. Experimentation on finding a gene cream to treat psoriasis in Australia; Announcement on the phase three study on the formulation of two percent ketoconazole in Connetics Corp.; Response of acyclic nucleoside phosphate analogue in...

Next 50 Results